Documentos relacionados

1. Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia.
2. Metabolic Rewiring and Altered Glial Differentiation in an iPSC-Derived Astrocyte Model Derived from a Nonketotic Hyperglycinemia Patient.
3. Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined nonketotic hyperglycinemia and lipoate deficiency.
4. Large scale analyses of genotype-phenotype relationships of glycine decarboxylase mutations and neurological disease severity.
5. [Responses to a reader's question on the article "Clinical and genetic analyses of a family with atypical nonketotic hyperglycinemia caused by compound heterozygous"].
6. Genomic analyses of glycine decarboxylase neurogenic mutations yield a large-scale prediction model for prenatal disease.
7. Homozygosity for disease-causing variants in AMT and GLDC in a patient with severe nonketotic hyperglycinemia.
8. Biallelic start loss variant, c.1A > G in GCSH is associated with variant nonketotic hyperglycinemia.
9. Novel compound heterozygous LIAS mutations cause glycine encephalopathy.
10. AAV-mediated expression of mouse or human GLDC normalises metabolic biomarkers in a GLDC-deficient mouse model of Non-Ketotic Hyperglycinemia.